Haemophilus Type b Conjugate Vaccine

Scheme

Ph. Eur.

ATC (Anatomical Therapeutic Chemical Classification)

J07AG01

CAS registry number (Chemical Abstracts Service)

0126161-67-9

Therapeutic Categories

Active immunisation against haemophilus influenzae type b

Bacterial vaccine

Chemical Name

Preparation of a polysaccharide, derived from a suitable strain of Haemophilus influenzaetype b, covalently bound to a carrier protein. The polysaccharide, polyribosylribitol phosphate (PrP) is a linear copolymer composed of repeated units, with a defined (Ph. Eur.)

Foreign Names

• Vaccinum haemophili stirpis b coniugatum (Latin)
• Haemophilus Typ-B-Impfstoff, konjugiert (German)
• Vaccin conjugué de l'haemophilus type b (French)
• Vacuna contra Haemophilus influenzae tipo b (Spanish)

Generic Names

• Haemophilus influenzae B antigène purifié conjugué (IS)
• Haemophilus influenzae B-Impfstoff, konjugiert (IS)
• Haemophilus influenzae B-Polysaccharid-Konjugat-Impfstoff (IS)
• Haemophilus influenzae type b conjugate vaccine (IS)
• Haemophilus-influenzae-Typ-B-Impfstoff (IS: konjugiert)
• Hemophilus influenzae B vaccine (IS)
• Hib (IS)
• Hib vaccine (IS)
• HIB-Konjugat-Impfstoff (IS)
• Vaccino di emofilo tipo B coniugato (IS)
• Vaccinum haemophili stirpe b coniugatum (IS)
• Vaccinum haemophilus influenzae B (IS)
• Vacuna de haemophilus influenzae tipo b (IS)
• Haemophilus Type b Conjugate Vaccine (PH: BP 2016, Ph. Eur. 8)
• Haemophilus-Typ-B-Impfstoff (konjugiert) (PH: Ph. Eur. 8)
• Vaccin conjugué de l'haemophilus type b (PH: Ph. Eur. 8)
• Vaccinum haemophili stirpis b coniugatum (PH: Ph. Eur. 8)
• Haemophilus b conjugate vaccine (IS: tetanus toxoid conjugate)
• Haemophilus influenzae B-Saccharid-Tetanus-Konjugat-Impfstoff (IS)
• Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine (IS)
• Kapsel-Polysaccharid des Hib-Bakteriums, gebunden an Tetanus-Protein (IS)
• Polysaccharide capsulaire purifié de la bactérie Hib, lié à la protéine tétanique (IS)

Brand Names

• ACT-HIB
  Sanofi Pasteur, Cyprus; Sanofi Pasteur, Macedonia; Sanofi Pasteur, Poland; Sanofi Pasteur MSD, Sweden
• ACT-HIB (pediatric)
  Sanofi Pasteur, France
• Comvax (Haemophilus Type b Conjugate Vaccine and Hepatitis B)
  Merck, United States
• Hiberix
  GlaxoSmithKline, Malaysia; Wellcome Limited, Bosnia & Herzegowina
• Hiberix (pediatric)
  GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Thailand
• Menitorix (Haemophilus Type b Conjugate Vaccine and Meningococcal Group C Polysaccharide Conjugate Vaccine)
  GlaxoSmithKline, Poland
• PedvaxHIB
  Merck, United States
• Synflorix
  GlaxoSmithKline, Chile; GlaxoSmithKline, Myanmar
• Vaxem Hib
  Novartis Vaccines, Thailand
• actHIB
  Sanofi Pasteur, South Korea; Sanofi Pasteur, United States
• ACT-HIB
  Sanofi Pasteur, Bosnia & Herzegowina; Sanofi Pasteur, Denmark; Sanofi Pasteur, Italy; Sanofi Pasteur, Norway; Sanofi Pasteur, Thailand
• Act-HIB
  Sanofi Pasteur, Canada; Sanofi-Aventis, Hong Kong
• Hiberix
  GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Spain; GlaxoSmithKline, Italy; GlaxoSmithKline, Romania; GlaxoSmithKline, Singapore; IVZ, Slovenia; Smith Kline & French, Portugal
• Hiberix (pediatric)
  GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Ireland; GlaxoSmithKline, Poland; GlaxoSmithKline, United States

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer